FML FORTE Drug Patent Profile
✉ Email this page to a colleague
When do Fml Forte patents expire, and what generic alternatives are available?
Fml Forte is a drug marketed by Abbvie and is included in one NDA.
The generic ingredient in FML FORTE is fluorometholone. There are five drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the fluorometholone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fml Forte
A generic version of FML FORTE was approved as fluorometholone by AMNEAL on January 9th, 2024.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for FML FORTE?
- What are the global sales for FML FORTE?
- What is Average Wholesale Price for FML FORTE?
Summary for FML FORTE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Patent Applications: | 6,457 |
| Drug Prices: | Drug price information for FML FORTE |
| What excipients (inactive ingredients) are in FML FORTE? | FML FORTE excipients list |
| DailyMed Link: | FML FORTE at DailyMed |
Pharmacology for FML FORTE
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
US Patents and Regulatory Information for FML FORTE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie | FML FORTE | fluorometholone | SUSPENSION/DROPS;OPHTHALMIC | 019216-001 | Apr 23, 1986 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
